High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$60.9M
$60,942,657
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
VRTX
M
VERTEX PHARMACEUTICALS INC / MA
LEIDEN JEFFREY M
• Chair
Equity Compensation
2025-12-04
$91x2
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
Equity Compensation
|
2025-12-04 | $91x2 | M | Form 4 |
|
VRTX
M
VERTEX PHARMACEUTICALS INC / MA
LEIDEN JEFFREY M
• Chair
Equity Compensation
2025-12-03
$5,518,332Whalex2
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
Equity Compensation
|
2025-12-03 | $5,518,332Whalex2 | M | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
LEIDEN JEFFREY M
• Chair
10b5-1 Sell
2025-12-03
$28,650,337MEGAx12
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
10b5-1 Sell
|
2025-12-03 | $28,650,337MEGAx12 | S | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
Other
|
2025-11-14 | $4,700,491Largex2 | M | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
LEIDEN JEFFREY M
• Chair
10b5-1 Sell
2025-11-14
$23,624,306MEGAx3
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
10b5-1 Sell
|
2025-11-14 | $23,624,306MEGAx3 | S | Form 4 |
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
Other
|
2025-11-13 | $1,792,592Large | M | Form 4 |
|
VRTX
S
VERTEX PHARMACEUTICALS INC / MA
LEIDEN JEFFREY M
• Chair
10b5-1 Sell
2025-11-13
$8,668,014Whalex2
|
||||||
| VRTX |
VERTEX PHARMACEUTICALS INC / MA
|
Chair
10b5-1 Sell
|
2025-11-13 | $8,668,014Whalex2 | S | Form 4 |